Johns Hopkins University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count).
Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.
Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.
Top-decile sponsor footprint
Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
943 of 1,108 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,448 total, page 23 of 29
Trial of Carvedilol in Alzheimer's Disease
NCT01354444
The Johns Hopkins Transplant Infectious Diseases Prospective Cohort Study
NCT01986504
Safety Study of Analgesia After Craniotomy Surgery With End Tidal (ET) Carbon Dioxide (CO2) Monitoring
NCT01327677
Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site
NCT02137980
Multi-Method Health System Quality Improvement Intervention to Reduce Hypertension Disparities
NCT01566864
A Study of Novel Smoking Cessation Interventions in Current and Former Injection Drug Users
NCT01334736
Effect of Sedation on Diagnostic Injections
NCT01472835
The Detection of Glaucoma Using Pupillography
NCT01462526
Internet-Based Intervention to Improve Mental Health Outcomes for Abused Women
NCT01312103
Treatment of Acne Keloidalis Nuchae (Razor Bumps Behind the Neck) Using UV Light Therapy
NCT01328080
Nutrition Knowledge for Spanish-speaking Parents
NCT01296945
Effects of Dronabinol (Oral THC) on Cannabis Use
NCT01394185
Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds
NCT01285050
Meaningful Use of Technology to Improve Health Care Delivery
NCT01641380
Combined Effects of Alcohol and Caffeine
NCT01289561
The Respiratory Protection Effectiveness Clinical Trial
NCT01249625
Cognitive Stimulation
NCT01271413
Ondansetron, Alcohol Use, and Alcohol-Related Symptoms In HIV+ Persons
NCT01254877
Pharmacokinetics of Vitamin D in Multiple Sclerosis and in Health
NCT01667796
Impact of Information Prescriptions on Medication Adherence in Emergency Department (ED) Patients
NCT01174706
Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder
NCT01354314
Mouse Allergen and Asthma Intervention Trial
NCT01251224
Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles
NCT01283464
CNS Growth Factors Release and Changes in the Inflammatory Environment in Response to Electrical Stimulation in Subjects With Inflammatory Myelopathies
NCT01440452
Benefits of Post-Pyloric Feeding Tubes in Critically Ill Patients
NCT01343316
Dietary Interventions in Asthma Treatment: Sprouts Study
NCT01183923
Lifestyle Interventions for Seniors With Apnea
NCT01422863
Medications Development for Drug Abuse Disorders
NCT01188421
Effects of Mental Stimulation in Patients With Mild Cognitive Impairment
NCT01212692
Pharmacokinetic Interaction Study of Efavirenz and American Ginseng in Healthy Volunteers
NCT01136928
Broccoli Sprout Extracts Trial to See if NRF2 is Enhanced by Sulforaphane Treatment in Patients With COPD
NCT01335971
Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life
NCT01160367
Yoga for Persons With Severe Visual Impairment
NCT01366677
Cardiovascular Disease Education and Problem-Solving Training in People With Type 2 Diabetes
NCT00964587
Positron Emission Tomography (PET) Imaging of Glial Activation in Psychotic Disease States
NCT03257592
Evaluating Three Methods for Helping Syringe Exchangers Begin Methadone Maintenance
NCT01142986
Confocal Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Early Esophageal Cancer(CEBE Study)
NCT01124214
Physiology of Vestibular Dysfunction and Clinical Implications
NCT01383642
A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals
NCT01136356
Case Management Study for Postpartum Depression and Intimate Partner Violence
NCT00560027
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
NCT01278303
Assessing Cerebral Blood Flow Autoregulation During Surgery in the Head-up Position
NCT01225185
Conservative Therapy Versus Epidural Steroids for Cervical Radiculopathy
NCT01144923
Effect of Zonisamide on Cocaine Reinforcement, Craving, and Relapse
NCT01137890
Baerveldt Plate Area Comparison (BPAC)
NCT01159314
Tools to Optimize Patient Presentation After Onset of Exudative Age-Related Macular Degeneration (AMD)
NCT01337414
Personalized Risk Identification and Management for Arrhythmias and Heart Failure by ECG and MRI
NCT01353131
Prospective Randomized Trial of Anterograde Single Balloon Versus Spirus Enteroscopy
NCT01853241
Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers
NCT01162486
Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric Conditions
NCT01368432
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 201 |
| Phase 2 | 198 |
| Phase 3 | 44 |
| Phase 4 | 81 |
Therapeutic Areas
What is open in the Johns Hopkins University pipeline
250 recruiting of 1,448 indexed (17% open); 943 completed (65%).
Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).
Top condition: Hypertension (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Johns Hopkins University: open-pipeline peers nationwide
Peers matched on 1,448 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Johns Hopkins University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,448 trials (± recruiting share)
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Yale University · 1,492 trials · 17% recruiting
- Washington University School of Medicine · 1,502 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Seattle Children's Hospital · 17% recruiting · 168 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
- Virginia Polytechnic Institute and State University · 17% recruiting · 104 trials
Related
What to do with this Johns Hopkins University page
1,448 registered trials is a research-attention snapshot, not an endorsement of Johns Hopkins University or any single study.
- 250 of Johns Hopkins University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition Johns Hopkins University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Johns Hopkins University pipeline card: 1,448 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.